Waldenström’s Macroglobulinemia: Clinical Features, Complications, and Management
Top Cited Papers
- 1 January 2000
- journal article
- review article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (1), 214
- https://doi.org/10.1200/jco.2000.18.1.214
Abstract
PURPOSE: To review the clinical features, complications, and treatment of Waldenström’s macroglobulinemia, a low-grade lymphoproliferative disorder that produces monoclonal immunoglobulin (Ig) M. M...Keywords
This publication has 123 references indexed in Scilit:
- Waldenström's macroglobulinemia*Cancer, 1998
- Waldenstr m's macroglobulinemiaCancer, 1997
- Acquired immunobullous disease: a cutaneous manifestation of IgM macroglobulinaemiaBritish Journal of Dermatology, 1996
- Infectious complications after 2‐chlorodeoxyadenosine therapyEuropean Journal of Haematology, 1996
- Waldenström's macroglobulinaemia secreting a paraprotein with lupus anticoagulant activity: possible association with gastrointestinal tract disease and malabsorption.Journal of Clinical Pathology, 1993
- Complement-Mediated Demyelination in Patients with IgM Monoclonal Gammopathy and PolyneuropathyNew England Journal of Medicine, 1990
- Bone Marrow Histology in Waldenström's MacroglobulinaemiaScandinavian Journal of Haematology, 1983
- Successful doxorubicin therapy of primary macroglobulinemia resistant to alkylating agentsAmerican Journal of Hematology, 1980
- Biologic Activity of Cold-Reacting AutoantibodiesNew England Journal of Medicine, 1977
- Incipient myelomatosis or «essential« hyperglobulinemia with fibrinogenopenia — a new syndrome?Acta Medica Scandinavica, 1944